These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14527056)

  • 1. HCV in sickle cell disease.
    Hassan M; Hasan S; Castro O; Giday S; Banks A; Smoot D
    J Natl Med Assoc; 2003 Sep; 95(9):864-7, 872-4. PubMed ID: 14527056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus in sickle cell disease.
    Hassan M; Hasan S; Giday S; Alamgir L; Banks A; Frederick W; Smoot D; Castro O
    J Natl Med Assoc; 2003 Oct; 95(10):939-42. PubMed ID: 14620705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle cell anaemia in Enugu, South East Nigeria.
    Ejiofor OS; Ibe BC; Emodi IJ; Ikefuna AN; Ilechukwu GC; Emechebe G; Ilechukwu C
    Niger J Clin Pract; 2009 Dec; 12(4):355-8. PubMed ID: 20329670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C in patients with sickle cell disease.
    Hasan MF; Marsh F; Posner G; Bellevue R; Dosik H; Suatengco R; Ramani N
    Am J Gastroenterol; 1996 Jun; 91(6):1204-6. PubMed ID: 8651171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to "Hepatitis C virus, sickle cell disease treatment options"--a February letter to the editor.
    Smoot DT
    J Natl Med Assoc; 2004 Mar; 96(3):383. PubMed ID: 15040523
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital.
    Lesi OA; Kehinde MO
    Niger Postgrad Med J; 2003 Jun; 10(2):79-83. PubMed ID: 14567040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus genotype 5 in Mexico: a case report with successful treatment and a literature review].
    Rubio-Lezama MA; López-Alférez R; Santillán-Arreygue L; Romero-Figueroa M
    Rev Gastroenterol Mex; 2013; 78(3):191-5. PubMed ID: 23972822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection.
    Lauer GM; Walker BD
    N Engl J Med; 2001 Jul; 345(1):41-52. PubMed ID: 11439948
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy for chronic hepatitis C viral infection.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():3-7. PubMed ID: 8720286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.